0001415889-22-006493.txt : 20220613 0001415889-22-006493.hdr.sgml : 20220613 20220613163040 ACCESSION NUMBER: 0001415889-22-006493 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220609 FILED AS OF DATE: 20220613 DATE AS OF CHANGE: 20220613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reeve Emma CENTRAL INDEX KEY: 0001680329 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 221012036 MAIL ADDRESS: STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION STREET 2: 195 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 form4-06132022_040629.xml X0306 4 2022-06-09 0001650664 Editas Medicine, Inc. EDIT 0001680329 Reeve Emma C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 true false false false Stock Option (right to buy) 12.31 2022-06-09 4 A 0 25000 0 A 2032-06-08 Common Stock 25000 25000 D This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023. /s/ Emma Reeve 2022-06-13